(Total Views: 473)
Posted On: 01/04/2021 2:12:29 PM
Post# of 145248
That drug would have the same effect on mTORc1 as leronlimab. The inhibition of mTORc1 controls a wide variety of cancer fighting activities. Leronlimab being upstream of mTORc1 and controlling more immunity factors than only that should be quite a bit superior.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)